Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pterovita is a patented nutraceutical ingredient developed by CIRCE Scientific, consisting of a cocrystal that combines the stilbenoid pterostilbene with picolinic acid. Engineered using a proprietary digital platform, this cocrystal formulation is designed to overcome the inherent solubility and bioavailability limitations of standard pterostilbene. Pterostilbene, a natural antioxidant found in blueberries, serves as a potent activator of Sirtuin 1 (SIRT1), a protein associated with longevity and metabolic regulation. Clinical data indicates that the Pterovita formulation enhances the maximum blood concentration (Cmax) of pterostilbene in humans by at least 7.5 times compared to conventional forms. It is marketed for use in dietary supplements, functional foods, and cosmetics to support general health, healthy aging, metabolic wellness, and anti-inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pterovita.